Detalhe da pesquisa
1.
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.
Circulation
; 149(12): 932-943, 2024 03 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38264923
2.
Evaluation of obstructive sleep apnea among consecutive patients with all patterns of atrial fibrillation using WatchPAT home sleep testing.
Am Heart J
; 261: 95-103, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37019195
3.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33587654
4.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33587659
5.
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
Circulation
; 143(5): 470-478, 2021 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33185476
6.
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.
Am Heart J
; 247: 24-32, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34990581
7.
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 42(17): 1698-1706, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33760027
8.
Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study.
Am Heart J
; 235: 132-139, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33493453
9.
A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the Coronavirus Disease 2019 Pandemic.
J Pharmacol Exp Ther
; 376(1): 12-20, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33115823
10.
Digital health device measured sleep duration and ideal cardiovascular health: an observational study.
BMC Cardiovasc Disord
; 21(1): 497, 2021 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34649522
11.
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Circulation
; 139(6): 760-771, 2019 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30586727
12.
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 140(22): 1792-1801, 2019 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31597460
13.
Atrial Fibrillation and Catheter Ablation.
N Engl J Med
; 387(14): e31, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36198177
14.
Atrial Fibrillation - What Is It and How Is It Treated?
N Engl J Med
; 387(16): e38, 2022 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36260791
15.
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 40(19): 1518-1527, 2019 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30590425
16.
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
Eur Heart J
; 40(19): 1541-1550, 2019 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30624719
17.
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 138(18): 1963-1973, 2018 10 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29967197
18.
Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial.
Europace
; 21(2): 306-312, 2019 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30462220
19.
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.
Eur Heart J
; 39(42): 3810-3820, 2018 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30239711
20.
Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs.
Circulation
; 135(21): 2062-2072, 2017 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28533319